Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > GNCA Genocea Biosciences > Detailed Quotes

GNCA Genocea Biosciences

Watchlist
0.0070.0000.00%
Close  12/06 16:00 ET
High
0.007
Open
0.001
Turnover
18.04
Low
0.001
Pre Close
0.007
Volume
12.03K
Market Cap
405.61K
P/E(TTM)
Loss
52wk High
1.480
Shares
58.78M
P/E(Static)
Loss
52wk Low
0.000
Float Cap
338.26K
Bid/Ask %
0.00%
Historical High
191.920
Shs Float
49.02M
Volume Ratio
0.29
Historical Low
0.000
Dividend TTM
--
Div Yield TTM
--
P/B
0.03
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.03%
Amplitude
84.06%
Avg Price
0.001
Lot Size
1
Float Cap
338.26K
Bid/Ask %
0.00%
Historical High
191.920
Shs Float
49.02M
Volume Ratio
0.29
Historical Low
0.000
Dividend TTM
--
P/B
0.03
Dividend LFY
--
Turnover Ratio
0.03%
Amplitude
84.06%
Avg Price
0.001
Lot Size
1
Price Forecast

News

Comment

Sign in to post a comment

No comment yet

Company Overview More
Genocea Biosciences, Inc. engages in the development and commercialization of cancer immunotherapies. The firm uses its proprietary technology platform, ATLAS, to identify clinically relevant antigens of T cells based on actual human immune responses. Its product candidates include GEN-011, an investigational adoptive T cell therapy and GEN-009, a neoantigen cancer vaccine. The company was founded by Robert Paull and Kevin J. Bitterman on August 16, 2006 and is headquartered in Cambridge, MA.
CEO: Mr. William D. Clark
Market: Pink Market
Listing Date: 02/05/2014
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist